Telix制药公司与Sptle Medical公司合作,利用AI-SptlePET技术将PET扫描时间减少75%。 Telix Pharmaceuticals partners with Subtle Medical to reduce PET scan times by 75% with AI-SubtlePET technology.
Telix Pharmaceuticals 与 Subtle Medical 合作，使用 AI 驱动的 SubtlePET™ 技术和 Telix 的 Illuccix® 代理来增强正电子发射断层扫描 （PET） 成像。 Telix Pharmaceuticals has partnered with Subtle Medical to enhance Positron Emission Tomography (PET) imaging using AI-powered SubtlePET™ technology with Telix's Illuccix® agent. 这种经FDA批准的解决方案可显著减少高达75%的扫描时间,提高患者的舒适度和医疗机构的运营效率. This FDA-cleared solution significantly reduces scan times by up to 75%, improving patient comfort and operational efficiency in medical facilities. 合作对象是北美和欧盟,并计划扩大到其他Telix PET-tracers,等待管制批准。 The collaboration targets North America and the EU, with plans to extend to other Telix PET-tracers pending regulatory approval.